HIS
WST icon

Harvest Investment Services’s West Pharmaceutical WST Stock Holding History

Harvest Investment Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-807
Closed -$244K – 163
2022
Q2 		$244K Sell
807
-4
-0.5% -$1.3K 0.19% 130
2022
Q1 		$333K Sell
811
-35
-4% -$13.7K 0.2% 142
2021
Q4 		$396K Sell
846
-32
-4% -$13.8K 0.17% 167
2021
Q3 		$372K Hold
878
– – 0.15% 185
2021
Q2 		$315K Buy
878
+2
+0.2% +$661 0.13% 201
2021
Q1 		$246K Sell
876
-774
-47% -$222K 0.11% 218
2020
Q4 		$467K Buy
1,650
+304
+23% +$85.3K 0.24% 108
2020
Q3 		$370K Buy
1,346
+38
+3% +$10.1K 0.21% 118
2020
Q2 		$297K Buy
+1,308
New +$257K 0.18% 138

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Investment Services's WST Position: Q3 2022 in Review

Harvest Investment Services sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 807 shares — an estimated $244K sold.

Harvest Investment Services first reported a position in WST in Q2 2020 and held it in 9 quarters. The position peaked at $467K in Q4 2020. 637 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Harvest Investment Services reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Harvest Investment Services sold 807 West Pharmaceutical shares in Q3 2022, an estimated $244K.
  • Harvest Investment Services first reported a position in West Pharmaceutical in Q2 2020 and held it in 9 quarters.
  • Harvest Investment Services's West Pharmaceutical position peaked at $467K in Q4 2020.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Harvest Investment Services's 13F filing for Q3 2022, filed 9 Nov 2022.